| Field | Specification |
|---|---|
| Mfr No | |
| Accession Number | |
| Alternative Names | 2019-nCoV S glycoprotein;2019-nCoV Spike glycoprotein;2019-nCov S protein |
| Endotoxin Level | |
| Formulation | |
| Product Type | |
| Purity | |
| Reconstitution | |
| Shipping | |
| Species | |
| Storage | |
| UniProt # |
Scientific Background
The spike (S) glycoprotein of coronaviruses contains protrusions that will only bind to certain receptors on the host cell. Known receptors bind S1 are ACE2, angiotensin-converting enzyme 2; DPP4, dipeptidyl peptidase-4; APN, aminopeptidase N; CEACAM, carcinoembryonic antigen-related cell adhesion molecule 1; Sia, sialic acid; O-ac Sia, O-acetylated sialic acid. The spike is essential for both host specificity and viral infectivity. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process.
Alternative names: 2019-nCoV S glycoprotein;2019-nCoV Spike glycoprotein;2019-nCov S protein
Product Description
Mammalian (HEK293) ExpressionThis recombinant protein is produced using a validated Mammalian (HEK293) expression system and supplied as liquid with C-His affinity tag. No reconstitution required. Suitable for biochemical binding assays, ELISA standard curves, antibody validation, protein interaction studies, and related research applications.
Protein Specifications
| UniProt ID | P0DTC2 |
|---|---|
| Expression System | Mammalian (HEK293) |
| Expression Region | Cys15-Gln1208 |
| Affinity Tag | C-His |
| Calculated MW | 136.6 kDa |
| Observed MW | 170-220 kDa |
| Purity | > 95% as determined by reducing SDS-PAGE. |
| Endotoxin | < 1.0 EU per μg of the protein as determined by the LAL method. |
| Formulation | Supplied as a 0.2 μm filtered solution of PBS, pH7.4. |
| Storage | Store at < -20°C, stable for 6 months. Please minimize freeze-thaw cycles. |
| Shelf Life | 12 months |
Functional Activity Data
Loaded Human ACE-2-Fc on Protein A Biosensor, can bind 2019-nCoV S-trimer Protein-His with an affinity constant of 0.125 nM as determined in BLI assay.
Safety & Handling
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
This protein was produced in Mammalian (HEK293) expression system. The expression system determines the protein post-translational modification profile, folding characteristics, and suitability for specific applications. Mammalian (HEK293) expression is used where native-like glycosylation is required; insect cell and E. coli systems are used for high-yield non-glycosylated production.
This product is supplied as liquid and does not require reconstitution. Centrifuge briefly, then aliquot into single-use working portions in 0.1% BSA carrier protein to minimise freeze-thaw degradation. Avoid repeated freeze-thaw of the bulk stock.
Endotoxin is < 1.0 EU per μg of the protein as determined by the LAL method., determined by the LAL chromogenic method. The <1.0 EU/µg specification ensures suitability for cell culture experiments, primary cell stimulation, and assays measuring immune activation or cytokine secretion, where endotoxin interference with NF-κB signalling is a concern.
This protein meets > 95% as determined by reducing SDS-PAGE purity as assessed by reducing SDS-PAGE. A gel image for each lot is included on the Certificate of Analysis. Contact technical support if purity >98% is required for biophysical measurements such as crystallography, ITC, or single-particle cryo-EM.
Store at < -20°C, stable for 6 months. Please minimize freeze-thaw cycles. Shelf life is 12 months from the date of receipt. Prepare small working aliquots to minimise freeze-thaw cycles of the bulk stock. Once thawed, store at 4°C for short-term use (up to 1 week) or refreeze aliquots immediately.
BioHippo offers flexible sourcing and customisation options for qualified research institutions and commercial partners. The following add-ons may be available depending on supplier capabilities and order volume.
- Custom quantities: Bulk orders or non-standard pack sizes may be available for high-throughput or large-scale projects.
- Custom formulation: Alternative buffer compositions or lyophilisation formats may be accommodated on request.
- Biotinylated or labelled variants: Biotinylated, fluorescent, or enzymatic conjugation services may be available for select proteins.
- Extended QC documentation: Endotoxin levels, bioactivity assay data, or additional purity methods can be requested for GMP-adjacent applications.
Contact BioHippo customer support to discuss requirements. Customisation availability and lead times vary by product and supplier.
1. Common human coronavirus-induced cross-reactive salivary antibodies exhibit neutralizing activity and protective potential against SARS-CoV-2
Journal of Microbiology, Immunology and Infection (2025) | IF: 3.700 | DOI: 10.1016/j.jmii.2025.12.004
2. Determining Site-Specific Glycan Profiles of Recombinant SARS-CoV-2 Spike Proteins from Multiple Sources
Journal of Proteome Research (2023) | IF: 4.400 | DOI: 10.1021/acs.jproteome.3c00271 | PMID: 37647588
3. A high-affinity aptamer with base-appended base-modified DNA bound to isolated authentic SARS-CoV-2 strains wild-type and B.1.617.2 (delta variant)
Biochemical and Biophysical Research Communications (2022) | IF: 3.322 | DOI: 10.1016/j.bbrc.2022.04.071 | PMID: 35617879